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Cholesterol metabolism and homeostasis in the central nervous system and their role in neuronal func-
tion represent important determinants in neuropathogenesis. The serotonin1A receptor is an important
member of the G-protein coupled receptor superfamily, and is involved in a variety of cognitive, behav-
ioral, and developmental functions. We report here, for the first time, that the ligand binding function of
human serotonin1A receptors exhibits an increase in membranes isolated from cholesterol-depleted neu-
ronal cells. Our results gain pharmacological significance in view of the recently described structural evi-
dence of specific cholesterol binding site(s) in GPCRs, and could be useful in designing better therapeutic
strategies for neurodegenerative diseases associated with GPCRs.
 2009 Elsevier Inc. All rights reserved.Introduction
The G-protein coupled receptor (GPCR) superfamily is the larg-
est and most diverse protein family in mammals, involved in signal
transduction across membranes [1]. GPCRs are increasingly recog-
nized as major targets for the development of novel drug candi-
dates in all clinical areas [2,3]. The serotonin1A (5-HT1A) receptor
is an important neurotransmitter receptor belonging to the GPCR
superfamily. It is the most extensively studied of the serotonin
receptors for a number of reasons [4,5]. Serotonergic signaling
plays a key role in the generation and modulation of various cogni-
tive, behavioral and developmental functions [6]. This is supported
by the fact that the agonists and antagonists of the serotonin1A
receptor represent major classes of molecules with potential ther-
apeutic effects in anxiety- and stress-related disorders. Interest-
ingly, mutant (knockout) mice lacking the serotonin1A receptor
exhibit enhanced anxiety-related behavior, and represent an
important animal model for genetic vulnerability to complex traits
such as anxiety disorders and aggression in higher animals [7,8]. In
the context of increasing pharmacological relevance of the seroto-
nin1A receptor, a transmembrane protein, its interaction with sur-ll rights reserved.
ine-1A receptor; 8-OH-DPAT,
choninic acid; DMPC, 1,2-
,6-diphenyl-1,3,5-hexatriene;
cyclodextrin; PMSF, phenyl-
ay).rounding lipids assumes significance in modulating the function of
the receptor in healthy and diseased states [5].
Cholesterol is an essential and representative lipid in higher
eukaryotic cellularmembranes and is crucial inmembrane organiza-
tion, dynamics, function, and sorting [9–11]. It is often found distrib-
uted non-randomly in domains in biological andmodel membranes.
Many of these domains (sometimes termed as ‘lipid rafts’) are be-
lieved to be important for the maintenance of membrane structure
and function. Nonetheless, characterizing the spatiotemporal resolu-
tion of these domains has proven to be challenging [11–14]. The idea
of such specializedmembrane domains assumes relevance in the cel-
lular context since physiologically important functions such asmem-
brane sorting and trafficking [15] signal transduction processes [16],
and the entry of pathogens [17–19] have been attributed to these do-
mains.Wehave earlier shown thatmembrane cholesterol is essential
for the function of the serotonin1A receptor (reviewed in [5] and [20]).
Mammalian cells in culture heterologously expressing mem-
brane receptors represent convenient systems to address problems
in receptor biology due to higher expression levels of receptors
[21]. An important consideration in such expression systems is
selectinga cell typewhich isderived fromthe tissueofnatural occur-
rence of the receptor. This is particularly true for receptors of neural
origin since the membrane lipid composition of cells in the nervous
system is unique and displays remarkable diversity [22–24]. Lipids
found in neuronal membranes are often necessary for maintaining
the structure and function of neuronal receptors. Keeping this in
mind, we earlier reported the pharmacological and functional char-
acterization of the human serotonin1A receptor stably expressed in
HN2 cells [25], which are a hybrid cell line between hippocampal
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serotonin1A receptor expressed in HN2 cells displays characteristic
features found in the native receptor isolated from bovine hippo-
campus and represents a realistic model system for the receptor.
In this paper, we monitored the function of the human serotonin1A
receptor stably expressed in HN2 cells upon depletion of membrane
cholesterol from live cells. Cholesterol depletion from cell mem-
branes was achieved usingmethyl-b-cyclodextrin (MbCD). The cor-
responding changes in membrane dynamics were monitored by
fluorescence anisotropy of the membrane probe DPH. Importantly,
our results show that the ligand binding function of serotonin1A
receptors is enhanced in membranes isolated from cholesterol-de-
pleted neuronal cells. This constitutes the first report describing
functional changes in serotonin1A receptors uponmembrane choles-
terol depletion in neuronal cells.Fig. 1. Fold change in specific binding of the agonist [3H]8-OH-DPAT to serotonin1A
receptors from HN2-5-HT1AR cell membranes with increasing amounts of total
membrane protein. Values have been normalized with respect to specific binding
obtained with 110 lg total protein in the assay. Concentration of [3H]8-OH-DPAT
used in the assay was 0.29 nM. Data represent means ± SE from three independent
measurements. See Materials and methods for other details.Materials and methods
Materials. Cholesterol, MbCD, DMPC, DPH, EDTA, MgCl2, MnCl2,
Na2HPO4, PMSF, serotonin, polyethylenimine, and Tris were ob-
tained from Sigma Chemical Co. (St. Louis, MO). DMEM (Dulbecco’s
modified Eagle’s medium), fetal calf serum, and geneticin (G 418)
were from Invitrogen Life Technologies (Carlsbad, CA). Amplex
Red cholesterol assay kit was from Molecular Probes (Eugene,
OR). BCA reagent for protein estimation was from Pierce (Rockford,
IL). [3H]8-OH-DPAT (sp. activity 106 Ci/mmol) was purchased from
DuPont New England Nuclear (Boston, MA). GF/B glass microfiber
filters were from Whatman International (Kent, UK). Water was
purified through a Millipore (Bedford, MA) Milli-Q system and
used throughout. All other chemicals and solvents used were of
the highest available purity.
Cells and cell culture. The intronless human genomic clone G-21
[26] which encodes the human serotonin1A receptor was used to
generate stable transfectants in HN2 cells which are a hybrid cell
line between hippocampal cells and mouse neuroblastoma [27].
These cells stably expressing the human serotonin1A receptor are
referred to as HN2-5-HT1AR cells [25]. HN2-5-HT1AR cells were
maintained as described earlier [25,28].
Cholesterol depletion of neuronal cells in culture. Cells at density
of 2  106 in 150 cm2 flasks were grown for 3 days in DMEM sup-
plemented with 10% serum, followed by incubation in serum-free
DMEM for 3 h at 37 C. Cholesterol depletion was carried out by
treating cells with increasing concentrations of MbCD in serum-
free DMEM for 30 min at 37 C, followed by wash with 10 mM so-
dium phosphate, 150 mM sodium chloride, pH 7.4 buffer.
Cell membrane preparation. Cell membranes were prepared as
described earlier [25]. Total protein concentration in isolated
membranes was determined using the BCA assay [29].
Radioligand binding assay. Receptor binding assays in mem-
branes isolated from control and cholesterol-depleted HN2-5-
HT1AR cells were carried out as described earlier [25,30] with
200 lg total protein. The concentration of [3H]8-OH-DPAT used
was 0.29 nM.
Analysis of cholesterol and phospholipid contents. Cholesterol
content in cell membranes was estimated using the Amplex Red
cholesterol assay kit [31]. Total phospholipid content of mem-
branes was determined subsequent to digestion with perchloric
acid [32] using Na2HPO4 as standard. DMPC was used as an inter-
nal standard to assess lipid digestion. Samples without perchloric
acid digestion produced negligible readings.
Fluorescence anisotropy measurements. Steady state fluorescence
anisotropy measurements were carried out in a Hitachi F-4010
spectrofluorometer using the fluorescent probe DPH incorporated
in membranes isolated from control and cholesterol-depleted
HN2-5-HT1AR cells, as mentioned earlier [33]. Fluorescenceanisotropy measurements were performed using a Hitachi polari-
zation accessory. Anisotropy values were calculated from the equa-
tion [34]:
r ¼ IVV  GIVH
IVV þ 2GIVH
where IVV and IVH are the measured fluorescence intensities (after
appropriate background subtraction) with the excitation polarizer
vertically oriented and the emission polarizer vertically and hori-
zontally oriented, respectively. G is the grating correction factor
and is equal to IHV/IHH. Experiments were done with multiple sets
of samples and average values of fluorescence anisotropy are shown
in Fig. 4.
Statistical analysis: Significance levels were estimated using Stu-
dent’s two-tailed unpaired t-test using Graphpad Prism software
version 4.0 (San Diego, CA).
Results and discussion
We monitored specific binding of the serotonin1A receptor ago-
nist [3H]8-OH-DPAT to membranes isolated from HN2-5-HT1AR
cells. Fig. 1 shows that the binding of the [3H]8-OH-DPAT is linear
over a broad range (30–200 lg) of total protein. These results sug-
gest that under the conditions of the assay, there is no depletion of
the radiolabel during the course of the assay. These conditions are
therefore appropriate for analyzing binding parameters of the
receptor using [3H]8-OH-DPAT [35].
MbCD is a water-soluble cyclic oligosaccharide, and has earlier
been shown to extract cholesterol from membranes in a selective
and efficient manner by including it in a central nonpolar cavity
[36]. Fig. 2 shows the cholesterol content in membranes isolated
from control and cholesterol-depleted HN2-5-HT1AR cells. Treat-
ment of cells with increasing concentrations of MbCD results in a
progressive depletion of membrane cholesterol. When membranes
were treated with 10 mM MbCD, the cholesterol content was re-
duced to 35% of that of control (without treatment). The concen-
tration range of MbCD was carefully chosen to minimize any
possible change in membrane phospholipid content. The phospho-
lipid content remains invariant under these conditions (see inset of
Fig. 2).
Fig. 3 shows the increase in specific [3H]8-OH-DPAT binding in
membranes isolated from HN2-5-HT1AR cells upon treatment with
increasing concentrations of MbCD. For example, specific agonist
binding is enhanced by 47% of the control (in the absence of
Fig. 2. Lipid contents of membranes isolated from HN2-5-HT1AR cells upon
cholesterol depletion. The figure depicts cholesterol contents in membranes
isolated from control cells and cells treated with increasing concentrations of
MbCD. The inset shows the corresponding phospholipid content in membranes
isolated from cholesterol-depleted HN2-5-HT1AR cells. Values are expressed as
percentages of the respective lipid content in control (without MbCD treatment)
cell membranes. Data shown are means ± SE from at least four independent
measurements. See Materials and methods for other details.
Fig. 3. Effect of cholesterol depletion on specific binding of the agonist to human
serotonin1A receptors in membranes isolated from control and MbCD-treated HN2-
5-HT1AR cells. The figure shows specific [3H]8-OH-DPAT binding to receptors in
membranes isolated from cells treated with increasing concentrations of MbCD.
Values are expressed as percentages of specific binding obtained in control cells
without MbCD treatment. Data represent means ± SE from at least six independent
measurements performed in duplicate. See Materials and methods for other details.
Fig. 4. Steady state fluorescence anisotropy of the membrane probe DPH in
membranes isolated from cholesterol-depleted HN2-5-HT1AR cells. Fluorescence
anisotropy measurements were carried out with membranes containing 50 nmol
phospholipid at a probe to phospholipid ratio of 1:100 (mol/mol) at room
temperature (23 C). The excitation wavelength was 358 nm and emission was
monitored at 430 nm. Data represent means ± SE from at least four independent
measurements. See Materials and methods for other details.
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removal of cholesterol from intact HN2-5-HT1AR cells leads to
enhancement of specific agonist binding to serotonin1A receptors.
To the best of our knowledge, these results constitute the first
report on change in ligand binding function of serotonin1A recep-
tors upon cholesterol modulation in neuronal cells.
The observed increase in specific ligand binding function upon
reduction in membrane cholesterol content could be due to an
alteration in overall membrane organization. In order to monitor
the change in overall membrane order, we monitored the steady
state fluorescence anisotropy of the membrane probe, diphenyl-
hexatriene (DPH). DPH is a rod-like molecule and partitions into
the bilayer, irrespective of the phase (ordered/disordered) of the
membrane [37]. Fluorescence anisotropy is correlated to the rota-
tional diffusion of membrane embedded probes such as DPH [34],
which is sensitive to the packing of lipid acyl chains. This is due to
the fact that fluorescence anisotropy depends on the degree to
which the probe is able to reorient after excitation, and probereorientation is a function of local lipid packing. Fig. 4 shows the
steady state fluorescence anisotropy of DPH in membranes isolated
from control and cholesterol-depleted HN2-5-HT1AR cells. Interest-
ingly, the fluorescence anisotropy does not exhibit any appreciable
change in membranes isolated from cholesterol-depleted cells.
This implies that the overall membrane order is not significantly
(p > 0.05) altered upon cholesterol depletion.
A useful approach for performing pharmacological studies on
GPCRs is to use a functional receptor system that converts recep-
tor–ligand interaction into a cellular signal which allows tomonitor
the relationship between concentration and response [38]. In the
past few years, there have been an increasing number of genetically
engineered recombinant receptor systems for monitoring drug–
receptor interactions. This has led to a corresponding increase in
the testing of newdrugs in recombinant receptor systems. However,
differences in host membrane lipid composition often complicate
interpretation of drug testing results in such systems, and can lead
to receptors with characteristics different from native receptors.
For example, it has earlier been reported that although the rat corti-
cal serotonin1A receptor exists only in the high affinity state in its na-
tive environment, it displays both high and low affinity when
expressed inHEK293 cells [39]. It is therefore judicious toworkwith
cellular systems in which the membrane lipid composition closely
mimics the native lipid environment. Our choice of HN2 cells for
exploring the interaction between membrane cholesterol and sero-
tonin1A receptors is based on the observation that cell lines of neural
origin represent realisticmodels for understanding signal transduc-
tion in neuronal cells.
Cholesterol metabolism and homeostasis in the central nervous
system and their role in neuronal function is only beginning to be
addressed [40]. Previous work from our laboratory has shown that
depletion of cholesterol from isolated hippocampal membranes
using MbCD leads to the reduction in ligand binding of the seroto-
nin1A receptor [41]. In this context, our present observation of
increase in agonist binding of serotonin1A receptors in membranes
isolated from cholesterol-depleted HN2-5-HT1AR cells appears
interesting. Our present results imply that specific ligand binding
to serotonin1A receptors upon cholesterol depletion is influenced
by whether cholesterol depletion is carried out in isolated mem-
branes or from intact cells. These results assume additional rele-
vance since they represent the first report on change in ligand
binding function of serotonin1A receptors upon cholesterol deple-
tion in neuronal cells. This is important in the context of the recent
96 R. Prasad et al. / Biochemical and Biophysical Research Communications 390 (2009) 93–96observation that cholesterol depletion from neuronal and non-
neuronal cells differentially modulates the function of the G-pro-
tein coupled d-opioid receptor [42]. Overall, our results are rele-
vant in understanding the interaction of membrane cholesterol
with GPCRs, particularly in view of the recently described struc-
tural evidence of specific cholesterol binding site(s) in GPCRs [43].
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